Literature DB >> 27387501

Citrobacter rodentium NleB Protein Inhibits Tumor Necrosis Factor (TNF) Receptor-associated Factor 3 (TRAF3) Ubiquitination to Reduce Host Type I Interferon Production.

Xiaofei Gao1, Thanh H Pham2, Leigh Ann Feuerbacher3, Kangming Chen3, Michael P Hays3, Gyanendra Singh4, Christian Rueter5, Ramon Hurtado-Guerrero6, Philip R Hardwidge7.   

Abstract

Interferon signaling plays important roles in both intestinal homeostasis and in the host response to pathogen infection. The extent to which bacterial pathogens inhibit this host pathway is an understudied area of investigation. We characterized Citrobacter rodentium strains bearing deletions in individual type III secretion system effector genes to determine whether this pathogen inhibits the host type I IFN response and which effector is responsible. The NleB effector limited host IFN-β production by inhibiting Lys(63)-linked ubiquitination of TNF receptor-associated factor 3 (TRAF3). Inhibition was dependent on the glycosyltransferase activity of NleB. GAPDH, a target of NleB during infection, bound to TRAF3 and was required for maximal TRAF3 ubiquitination. NleB glycosyltransferase activity inhibited GAPDH-TRAF3 binding, resulting in reduced TRAF3 ubiquitination. Collectively, our data reveal important interplay between GAPDH and TRAF3 and suggest a mechanism by which the NleB effector inhibits type I IFN signaling.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  bacterial pathogenesis; infection; innate immunity; interferon; signal transduction

Mesh:

Substances:

Year:  2016        PMID: 27387501      PMCID: PMC5000071          DOI: 10.1074/jbc.M116.738278

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  35 in total

1.  Virus interference. I. The interferon.

Authors:  A ISAACS; J LINDENMANN
Journal:  Proc R Soc Lond B Biol Sci       Date:  1957-09-12

Review 2.  The type III secretion injectisome, a complex nanomachine for intracellular 'toxin' delivery.

Authors:  Guy R Cornelis
Journal:  Biol Chem       Date:  2010-07       Impact factor: 3.915

3.  YopJ targets TRAF proteins to inhibit TLR-mediated NF-kappaB, MAPK and IRF3 signal transduction.

Authors:  Charles R Sweet; Joseph Conlon; Douglas T Golenbock; Jon Goguen; Neal Silverman
Journal:  Cell Microbiol       Date:  2007-06-30       Impact factor: 3.715

4.  Central role for type I interferons and Tyk2 in lipopolysaccharide-induced endotoxin shock.

Authors:  Marina Karaghiosoff; Ralf Steinborn; Pavel Kovarik; Gernot Kriegshäuser; Manuela Baccarini; Birgit Donabauer; Ursula Reichart; Thomas Kolbe; Christian Bogdan; Tomas Leanderson; David Levy; Thomas Decker; Mathias Müller
Journal:  Nat Immunol       Date:  2003-04-07       Impact factor: 25.606

5.  Toll-like receptor 9-induced type I IFN protects mice from experimental colitis.

Authors:  Kyoko Katakura; Jongdae Lee; Daniel Rachmilewitz; Gloria Li; Lars Eckmann; Eyal Raz
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

Review 6.  Role of virulence factors on host inflammatory response induced by diarrheagenic Escherichia coli pathotypes.

Authors:  Javier Sanchez-Villamil; Fernando Navarro-Garcia
Journal:  Future Microbiol       Date:  2015       Impact factor: 3.165

Review 7.  Immune defence in mice lacking type I and/or type II interferon receptors.

Authors:  M F van den Broek; U Müller; S Huang; R M Zinkernagel; M Aguet
Journal:  Immunol Rev       Date:  1995-12       Impact factor: 12.988

8.  IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway.

Authors:  Katherine A Fitzgerald; Sarah M McWhirter; Kerrie L Faia; Daniel C Rowe; Eicke Latz; Douglas T Golenbock; Anthony J Coyle; Sha-Mei Liao; Tom Maniatis
Journal:  Nat Immunol       Date:  2003-05       Impact factor: 25.606

9.  Mutagenesis and Functional Analysis of the Bacterial Arginine Glycosyltransferase Effector NleB1 from Enteropathogenic Escherichia coli.

Authors:  Tania Wong Fok Lung; Cristina Giogha; Kristina Creuzburg; Sze Ying Ong; Georgina L Pollock; Ying Zhang; Ka Yee Fung; Jaclyn S Pearson; Elizabeth L Hartland
Journal:  Infect Immun       Date:  2016-04-22       Impact factor: 3.441

10.  Bacterial effector binding to ribosomal protein s3 subverts NF-kappaB function.

Authors:  Xiaofei Gao; Fengyi Wan; Kristina Mateo; Eduardo Callegari; Dan Wang; Wanyin Deng; Jose Puente; Feng Li; Michael S Chaussee; B Brett Finlay; Michael J Lenardo; Philip R Hardwidge
Journal:  PLoS Pathog       Date:  2009-12-24       Impact factor: 6.823

View more
  10 in total

1.  The bacterial arginine glycosyltransferase effector NleB preferentially modifies Fas-associated death domain protein (FADD).

Authors:  Nichollas E Scott; Cristina Giogha; Georgina L Pollock; Catherine L Kennedy; Andrew I Webb; Nicholas A Williamson; Jaclyn S Pearson; Elizabeth L Hartland
Journal:  J Biol Chem       Date:  2017-08-31       Impact factor: 5.157

Review 2.  NLRP6 in host defense and intestinal inflammation.

Authors:  K Venuprasad; Arianne L Theiss
Journal:  Cell Rep       Date:  2021-04-27       Impact factor: 9.423

Review 3.  Type I and III Interferon in the Gut: Tight Balance between Host Protection and Immunopathology.

Authors:  Johanna Pott; Silvia Stockinger
Journal:  Front Immunol       Date:  2017-03-14       Impact factor: 7.561

4.  Structural basis for arginine glycosylation of host substrates by bacterial effector proteins.

Authors:  Jun Bae Park; Young Hun Kim; Youngki Yoo; Juyeon Kim; Sung-Hoon Jun; Jin Won Cho; Samir El Qaidi; Samuel Walpole; Serena Monaco; Ana A García-García; Miaomiao Wu; Michael P Hays; Ramon Hurtado-Guerrero; Jesus Angulo; Philip R Hardwidge; Jeon-Soo Shin; Hyun-Soo Cho
Journal:  Nat Commun       Date:  2018-10-16       Impact factor: 14.919

5.  High-Throughput Screening for Bacterial Glycosyltransferase Inhibitors.

Authors:  Samir El Qaidi; Congrui Zhu; Peter McDonald; Anuradha Roy; Pradip Kumar Maity; Digamber Rane; Chamani Perera; Philip R Hardwidge
Journal:  Front Cell Infect Microbiol       Date:  2018-12-18       Impact factor: 5.293

6.  Tubulin Folding Cofactor TBCB is a Target of the Salmonella Effector Protein SseK1.

Authors:  Juan Luis Araujo-Garrido; Fernando Baisón-Olmo; Joaquín Bernal-Bayard; Francisco Romero; Francisco Ramos-Morales
Journal:  Int J Mol Sci       Date:  2020-04-30       Impact factor: 5.923

7.  NleB/SseK-catalyzed arginine-glycosylation and enteropathogen virulence are finely tuned by a single variable position contiguous to the catalytic machinery.

Authors:  Ana García-García; Thomas Hicks; Samir El Qaidi; Congrui Zhu; Philip R Hardwidge; Jesús Angulo; Ramon Hurtado-Guerrero
Journal:  Chem Sci       Date:  2021-08-19       Impact factor: 9.825

Review 8.  Categorizing Sequences of Concern by Function To Better Assess Mechanisms of Microbial Pathogenesis.

Authors:  Todd J Treangen; Krista L Ternus; Gene D Godbold; Anthony D Kappell; Danielle S LeSassier
Journal:  Infect Immun       Date:  2021-11-15       Impact factor: 3.609

Review 9.  Bacteria-Catalyzed Arginine Glycosylation in Pathogens and Host.

Authors:  Xing Pan; Jie Luo; Shan Li
Journal:  Front Cell Infect Microbiol       Date:  2020-04-28       Impact factor: 5.293

10.  Repurposing Avasimibe to Inhibit Bacterial Glycosyltransferases.

Authors:  Md Kamrul Hasan; Samir El Qaidi; Peter McDonald; Anuradha Roy; Philip R Hardwidge
Journal:  Pathogens       Date:  2022-03-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.